跳至主要内容
临床试验/NL-OMON52187
NL-OMON52187招募中4 期

Suboxone (buprenorphine/naloxone) versus methadone opioid rotation in patients with escalated opioid use and chronic pain: a randomized trial. - SUMO

Radboud Universitair Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18 or over.
  • - Meet ICD-11 criteria for chronic pain.
  • - Using a prescribed opioid with a morphine equivalent dose of over 60 mg per
  • day for >=3 months.
  • - Have an opioid use disorder according to the DSM-5.
  • - Wish to be treated for their opioid use disorder.
  • - Willing to comply to study procedures.
  • - Be able to give informed consent.

排除标准

  • - Pregnant, lactating, or planning to become pregnant during the study period.
  • - Have already used buprenorphine or methadone in the last 4 weeks as a
  • maintenance therapy.
  • - Escalated use of another substance that prevents safe participation in the
  • - Have acute psychiatric comorbidity.
  • - Severe respiratory insufficiency or depression, such as severe chronic
  • obstructive pulmonary disease GOLD 3 or 4.
  • - Serious medical disease, such as severe liver dysfunction (Child-Pugh B or
  • C), severe renal dysfunction (eGFR (MDRD) <=29), heart failure, current brain
  • - A Q-T interval of >=450 ms on an electrocardiograph (ECG).
  • - Hypersensitivity or allergy for buprenorphine, naloxone, methadone or any
  • other substance in the preparations of these medications.

研究者

相似试验

Suboxone (buprenorphine/naloxone) versus methadone... | 临床试验